Watch The Full investigation on Friday, June 16th

“It’s immoral. It’s unethical. And it just has to be stopped.”

Insys Therapeutics made millions off of patients suffering chronic pain. Their deceptive marketing practices for Subsys, a fentanyl opioid spray meant only for cancer patients, was prescribed to people throughout the country, who became addicted to the powerful drug. 9 Investigates looked into this story more, and interviewed Randy Hood, partner at McGowan, Hood, Felder & Phillips, LLC, for the piece.

We invite you to check out the promo, and to watch the full investigation on Friday, June 16th. 9 Investigates | WSOC-TV